Stocks TelegraphStocks Telegraph
Stock Ideas

ABT Company Profile and Key Details

NYSE : ABT

Abbott Laboratories

$87.69
-0.695-0.79%
Open: 11:35 AM
64.94
BESG ScoreESG Rating

Price Chart

Stock Price Today

Abbott Laboratories (ABT) stock declined over -0.79%, trading at $87.69 on NYSE, down from the previous close of $88.38. The stock opened at $88.60, fluctuating between $86.83 and $88.60 in the recent session.

Stock Snapshot

88.38
Prev. Close
152.73B
Market Cap
86.83
Day Low
24.56
P/E Ratio
3.57
EPS (TTM)
2.48
Cash Flow per Share
88.6
Open
1.74B
Number of Shares
88.6
Day High
99.41%
Free Float in %
22.39
Book Value
2.09M
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
May 20, 202688.2088.7987.1088.387.83M
May 19, 202688.3689.3487.4188.8211.69M
May 18, 202684.8687.9284.4087.9112.34M
May 15, 202685.8986.4884.1384.4712.91M
May 14, 202684.1885.2784.0584.9010.87M
May 13, 202683.4084.2682.6983.8311.78M
May 12, 202683.4285.1083.0984.3516.39M
May 11, 202684.4484.4481.9782.5616.25M
May 08, 202687.1687.3184.0884.3210.89M
May 07, 202686.3288.3086.2587.0113.26M
May 06, 202687.5587.6986.1586.3012.45M
May 05, 202687.3187.8386.1687.1717.19M
May 04, 202689.1889.7287.3087.5414.72M
Apr 30, 202691.4891.4890.2990.7919.65M
Apr 29, 202693.6593.7291.3391.339M
Apr 28, 202693.8494.7993.2793.8611.54M
Apr 27, 202691.6293.2690.8892.8015.18M
Apr 23, 202691.6192.4990.7292.4812.99M
Apr 22, 202692.6294.0491.5991.7011.97M
Apr 21, 202695.6095.9192.6692.7217.15M

Contact Details

Abbott Park, IL 60064-6400

United States

https://www.abbott.com224 667 6100

About Company

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, M�ni�re's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Company Information

Employees114000
Beta0.74
Sales or Revenue$40.11B
5Y Sales Change%0.328%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Devices

Technical Performance

Short-term trend indicators are bullishly aligned (SMA20 4.07%, SMA50 -1.48%, SMA200 -8.79%). The stock’s 14-day RSI is 56.54 (neutral), while the ATR of 2.26 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -17.69% below its high and over 10.42% above its low. Average 10-day trading volume of 12.51 million shares is in line with the 3-month average of 12.47 million, indicating normal recent market interest.

Frequently Asked Questions

What is the current Abbott Laboratories (ABT) stock price?
Abbott Laboratories (NYSE: ABT) stock price is $87.69 in the last trading session. During the trading session, ABT stock reached the peak price of $88.60 while $86.83 was the lowest point it dropped to. The percentage change in ABT stock occurred in the recent session was -0.79% while the dollar amount for the price change in ABT stock was - $0.70.
ABT's industry and sector of operation?
The NYSE listed ABT is part of Medical - Devices industry that operates in the broader Healthcare sector. Abbott Laboratories designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of ABT?
Mr. Joseph J. Manning
Executive Vice President of Nutritional Products
Mr. Scott Michael Leinenweber
SVice President of Licensing, Acquisitions & Ventures
Ms. Elaine R. Leavenworth
Senior Vice President and Chief Marketing & External Affairs Officer
James E. Young
Vice President and Chief Ethics & Compliance Officer
Dr. John M. Capek
Executive Vice President of Ventures
Mr. Robert B. Ford
Chairman, Pres & Chief Executive Officer
Mr. Robert E. Funck Jr.
Executive Vice President of Fin. & Chief Financial Officer
Mr. Hubert L. Allen
Executive Vice President, Gen. Counsel & Sec.
Ms. Andrea F. Wainer
Executive Vice President of Rapid & Molecular Diagnostics
Erica L. Battaglia
Vice President and Chief Ethics & Compliance Officer
Ms. Melissa Brotz
Vice President of Public Affairs & Corporation Marketing
Ms. Mary K. Moreland
Executive Vice President of HR
Mr. Jared L. Watkin
Senior Vice President of Diabetes Care
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group Pres of Established Pharmaceuticals & Nutritional Products
How ABT did perform over past 52-week?
ABT's closing price is 7.8% higher than its 52-week low of $81.97 where as its distance from 52-week high of $139.06 is -36.46%.
How many employees does ABT have?
Number of ABT employees currently stands at 114,000.
Link for ABT official website?
Official Website of ABT is: https://www.abbott.com
How do I contact ABT?
ABT could be contacted at phone 224 667 6100 and can also be accessed through its website. ABT operates from 100 Abbott Park Road, Abbott Park, IL 60064-6400, United States.
How many shares of ABT are traded daily?
ABT stock volume for the day was 2.09M shares. The average number of ABT shares traded daily for last 3 months was 12.27M.
What is the market cap of ABT currently?
The market value of ABT currently stands at $152.73B with its latest stock price at $87.69 and 1.74B of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph